Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter.
To determine what factors can predict conversion to sinus rhythm, we retrospectively studied 201 consecutive patients who received ibutilide for treatment of atrial fibrillation or flutter. On multivariate analysis, the following factors were significantly associated with conversion: recent onset of arrhythmia, an underlying atrial flutter rhythm, lack of a history of congestive heart failure, and lack of concomitant digoxin therapy.
Zaqqa
M
M
Texas Heart Institute at St. Luke's Episcopal Hospital, and Baylor College of Medicine, Houston, USA.
Afshar
H
H
Rasekh
A
A
Khoshnevis
R
R
Vaughn
W K
WK
Massumi
A
A
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D001282:Atrial Flutter / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D016009:Chi-Square Distribution; D004562:Electrocardiography / Q000379:methods; D005260:Female; D006339:Heart Rate; D006801:Humans; D016015:Logistic Models; D008297:Male; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012307:Risk Factors; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D013449:Sulfonamides; C067192:ibutilide